Immunologic studies of antihemophilic factor (AHF, factor VIII) II. Properties of cross-reacting material

In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.

Thrombosis research·2001

Mechanism of the immune response to human factor VIII in murine hemophilia A.

Thrombosis and haemostasis·2001

Characterization of the immune response to factor VIII using hemophilia A* mice.

Haematologica·2001

Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.

European journal of immunology·2000

Prevention and treatment of factor VIII inhibitors in murine hemophilia A.

Blood·2000

Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.

Thrombosis and haemostasis·1999

KPNA2-Mediated MYC Nuclear Import Enhances CAR-T Cell Memory and Potentiates Antitumor Efficacy.

Blood·2026

How I Identify and Diagnose Carriers of Hemophilia and Women and Girls with Hemophilia.

Blood·2026

The origins of rare glycosylphosphatidylinositol-deficient cells in normal and immune-mediated hematopoiesis.

Blood·2026

How I Treat Heavy Menstrual Bleeding in Patients with Bleeding Disorder of Unknown Cause.

Blood·2026

Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

Blood·2026

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

Blood·2026

Case Report: Efgartigimod in refractory non-tumor Lambert-Eaton myasthenic syndrome.

Frontiers in immunology·2026

Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls.

Frontiers in immunology·2026

Circulating angiogenic T cells as potential immune-vascular biomarkers associated with disease activity in axial spondyloarthritis.

Frontiers in immunology·2026

Immune profiling of anti-SSA-positive at-risk individuals reveals increased type I IFN activity preceding lymphocyte abnormalities in Sjögren's disease.

Frontiers in immunology·2026

Case Report: IgG4-related lung disease.

Frontiers in immunology·2026

Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review.

Frontiers in nephrology·2026

Related Experiment Videos

Immunologic studies of antihemophilic factor (AHF, factor VIII) II. Properties of cross-reacting material

Related Concept Videos

In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.

Mechanism of the immune response to human factor VIII in murine hemophilia A.

Characterization of the immune response to factor VIII using hemophilia A* mice.

Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer.

Prevention and treatment of factor VIII inhibitors in murine hemophilia A.

Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.

KPNA2-Mediated MYC Nuclear Import Enhances CAR-T Cell Memory and Potentiates Antitumor Efficacy.

How I Identify and Diagnose Carriers of Hemophilia and Women and Girls with Hemophilia.

The origins of rare glycosylphosphatidylinositol-deficient cells in normal and immune-mediated hematopoiesis.

How I Treat Heavy Menstrual Bleeding in Patients with Bleeding Disorder of Unknown Cause.

Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

Case Report: Efgartigimod in refractory non-tumor Lambert-Eaton myasthenic syndrome.

Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls.

Circulating angiogenic T cells as potential immune-vascular biomarkers associated with disease activity in axial spondyloarthritis.

Immune profiling of anti-SSA-positive at-risk individuals reveals increased type I IFN activity preceding lymphocyte abnormalities in Sjögren's disease.

Case Report: IgG4-related lung disease.

Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review.

Related Experiment Videos

Immunologic studies of antihemophilic factor (AHF, factor VIII) II. Properties of cross-reacting material

Related Concept Videos

Related Articles